Giles Baker is VP at Dolby Laboratories, Inc. (DLB). They have made 15 open-market trades across 1 company since 2018, most recently 2020-12-23.
CIK 0001731843
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DLB | 54,226 | $3.3M |
Shares reported on the most recent Form 4, priced at the 2020-12-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DLB | SELL | 2020-12-23 | 2020-12-23 | $94.00 | $2.1M | +0.6% | -0.6% | +3.1% |
| DLB | SELL | 2020-12-17 | 2020-12-21 | $91.97 | $579K | +2.2% | +2.4% | +7.3% |
| DLB | SELL | 2020-12-16 | 2020-12-17 | $91.14 | $650K | +5.2% | +1.5% | +8.0% |
| DLB | SELL | 2020-12-04 | 2020-12-07 | $91.00 | $2.0M | +1.8% | +4.9% | +8.7% |
| DLB | SELL | 2020-11-16 | 2020-11-18 | $87.21 | $13.9M | +2.3% | +5.9% | +8.3% |
| DLB | SELL | 2020-08-31 | 2020-09-01 | $70.28 | $1.2M | -6.7% | -5.4% | +25.8% |
| DLB | SELL | 2020-01-02 | 2020-01-06 | $68.80 | $3.0M | +0.6% | +4.3% | -20.3% |
| DLB | SELL | 2019-12-17 | 2019-12-18 | $68.59 | $856K | +0.5% | +1.2% | -27.4% |
| DLB | SELL | 2019-05-07 | 2019-05-07 | $65.30 | $534K | -4.3% | -3.9% | -11.7% |
| DLB | SELL | 2019-05-06 | 2019-05-07 | $65.31 | $5.2M | -4.3% | -3.9% | -11.7% |
| DLB | SELL | 2019-05-06 | 2019-05-07 | $65.31 | $2.3M | -4.3% | -3.9% | -11.7% |
| DLB | SELL | 2018-12-18 | 2018-12-19 | $64.53 | $772K | -1.1% | +2.6% | +2.4% |
| DLB | SELL | 2018-08-23 | 2018-08-27 | $70.00 | $350K | -2.5% | -3.8% | -5.9% |
| DLB | SELL | 2018-06-14 | 2018-06-18 | $65.00 | $325K | -4.7% | -0.6% | +6.9% |
| DLB | SELL | 2018-02-27 | 2018-03-01 | $64.14 | $2.7M | +5.8% | -2.1% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.